A Q&A with Bree Mitchell, PhD, who leads strategic planning, scientific program development, organizational development, operations, and scientific collaboration building as the Associate Director of the OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR).
Scientists have long imagined how they could improve treatments for a host of diseases if they could better see how individual cells carry out the functions of life. That goal is now within reach at OHSU, thanks to a huge new investment in technology that allows researchers to view the makeup of molecules nearly down […]
The first time you meet Johnny Matheny is astonishing. You would be forgiven for wondering: can this be real? That’s because when Johnny reaches out to shake your hand, he’s extending his grasp with the world’s first mind-controlled robotic arm. He lost his arm to cancer, and what has replaced the missing limb is extraordinary. […]
Pictured Above: Achromatopsia clinical trial patient Annie Joiner. She’s seen the world throughout her life in black and white until a gene therapy clinical trial gave her a first glimpse of color. No one has looked at the colors on an iPhone with as much fascination as Annie Joiner has in the past couple of […]
Over the past decade, OHSU has built a unique, world-class ADHD research program that’s looking at the disorder from every angle – and finding promising answers. We sit down with Joel Nigg, Ph.D., the Director for the Division of Psychology at OHSU, to discuss his extensive ADHD research. Part I: Dr. Nigg talks about the […]
One of the most highly cited medical scientists in the world, Gordon Mills, M.D., will be joining the faculty of the OHSU Knight Cancer Institute. He will hold the new Wayne and Julie Drinkward Chair in Precision Oncology. The Drinkwards, who established the chair with a gift of $2.5 million to OHSU, are longtime supporters […]
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
